Cargando…
Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies
PURPOSE: Side effects and side-effect risk information can be provided using written medicine information. However, challenges exist in effectively communicating this information to consumers. This study aimed to explore broad consumer profiles relevant to ramipril and clopidogrel side-effect risk i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501347/ https://www.ncbi.nlm.nih.gov/pubmed/26185427 http://dx.doi.org/10.2147/PPA.S86414 |
_version_ | 1782381055127322624 |
---|---|
author | Tong, Vivien Raynor, David K Blalock, Susan J Aslani, Parisa |
author_facet | Tong, Vivien Raynor, David K Blalock, Susan J Aslani, Parisa |
author_sort | Tong, Vivien |
collection | PubMed |
description | PURPOSE: Side effects and side-effect risk information can be provided using written medicine information. However, challenges exist in effectively communicating this information to consumers. This study aimed to explore broad consumer profiles relevant to ramipril and clopidogrel side-effect risk information interpretation. METHODS: Three focus groups were conducted (n=18 consumers) exploring consumer perspectives, understanding and treatment decision making in response to ramipril and clopidogrel written medicine information leaflets containing side effects and side-effect risk information. All discussions were audio recorded, transcribed verbatim, and analyzed to explore consumer profiles pertaining to side-effect risk appraisal. RESULTS: Three consumer profiles emerged: glass half-empty, glass half-full, and middle-of-the-road consumers, highlighting the influence of perceived individual susceptibility, interpretation of side-effect risk information, and interindividual differences, on consumers’ understanding of side-effect risk information. All profiles emphasized the importance of gaining an understanding of individual side-effect risk when taking medicines. CONCLUSION: Written side-effect risk information is not interpreted uniformly by consumers. Consumers formulated their own construct of individual susceptibility to side effects. Health care professionals should consider how consumers interpret side-effect risk information and its impact on medication use. Existing risk communication strategies should be evaluated in light of these profiles to determine their effectiveness in conveying information. |
format | Online Article Text |
id | pubmed-4501347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-45013472015-07-16 Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies Tong, Vivien Raynor, David K Blalock, Susan J Aslani, Parisa Patient Prefer Adherence Original Research PURPOSE: Side effects and side-effect risk information can be provided using written medicine information. However, challenges exist in effectively communicating this information to consumers. This study aimed to explore broad consumer profiles relevant to ramipril and clopidogrel side-effect risk information interpretation. METHODS: Three focus groups were conducted (n=18 consumers) exploring consumer perspectives, understanding and treatment decision making in response to ramipril and clopidogrel written medicine information leaflets containing side effects and side-effect risk information. All discussions were audio recorded, transcribed verbatim, and analyzed to explore consumer profiles pertaining to side-effect risk appraisal. RESULTS: Three consumer profiles emerged: glass half-empty, glass half-full, and middle-of-the-road consumers, highlighting the influence of perceived individual susceptibility, interpretation of side-effect risk information, and interindividual differences, on consumers’ understanding of side-effect risk information. All profiles emphasized the importance of gaining an understanding of individual side-effect risk when taking medicines. CONCLUSION: Written side-effect risk information is not interpreted uniformly by consumers. Consumers formulated their own construct of individual susceptibility to side effects. Health care professionals should consider how consumers interpret side-effect risk information and its impact on medication use. Existing risk communication strategies should be evaluated in light of these profiles to determine their effectiveness in conveying information. Dove Medical Press 2015-07-09 /pmc/articles/PMC4501347/ /pubmed/26185427 http://dx.doi.org/10.2147/PPA.S86414 Text en © 2015 Tong et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Tong, Vivien Raynor, David K Blalock, Susan J Aslani, Parisa Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies |
title | Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies |
title_full | Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies |
title_fullStr | Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies |
title_full_unstemmed | Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies |
title_short | Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies |
title_sort | consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501347/ https://www.ncbi.nlm.nih.gov/pubmed/26185427 http://dx.doi.org/10.2147/PPA.S86414 |
work_keys_str_mv | AT tongvivien consumerinterpretationoframiprilandclopidogrelmedicationriskinformationimplicationsforriskcommunicationstrategies AT raynordavidk consumerinterpretationoframiprilandclopidogrelmedicationriskinformationimplicationsforriskcommunicationstrategies AT blalocksusanj consumerinterpretationoframiprilandclopidogrelmedicationriskinformationimplicationsforriskcommunicationstrategies AT aslaniparisa consumerinterpretationoframiprilandclopidogrelmedicationriskinformationimplicationsforriskcommunicationstrategies |